BML-259
BML-259 is a potent dual inhibitor of CDK5 and CDK2, exhibiting IC50 values of 64 nM and 98 nM, respectively. This compound is a valuable research tool for investigating cancer and neurodegenerative disease mechanisms in both cellular and animal models.
Product Specifications
CAS Number
267654-00-2
Product Name Alternative
P53, inhibit, Inhibitor, death, Alzheimer's, BML 259, BML259, BML-259, CAY 10554, cell, CDK5, CDK, CDK2, CAY10554, CAY-10554, Cyclin dependent kinase, disease, neurotoxicity, protein
Field of Research
Cell Biology, Neuroscience
Purity
>98%
Bioactivity
CDK5/p25 inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml) .
Smiles
CC (C) c1cnc (NC (=O) Cc2ccccc2) s1
Molecular Formula
C14H16N2OS
Molecular Weight
260.4
Storage Conditions
RT
Notes
For research use only.
Other Product Names
N- (5-isopropyl-thiazol-2-yl) phenylacetamide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
YBF46101 100 μg
Recombinant Bovine B2M/Beta-2-microglobulin Protein, C-His
Sign In for Pricing
View Details 
YP-W11211-01 48 Tests
Human Heat Shock Protein 47 (HSP-47) ELISA Kit
Sign In for Pricing
View Details YP-W11211-02 96 Tests
Human Heat Shock Protein 47 (HSP-47) ELISA Kit
Sign In for Pricing
View Details 